Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Activating STING1-dependent immune signaling in TP53 mutant and wild-type acute myeloid leukemia

Proceedings of the National Academy of Sciences(2022)10.1073/pnas.2123227119Source: DataRank Database

Activating STING1-dependent immune signaling in TP53 mutant and wild-type acute myeloid leukemia is a research paper published in Proceedings of the National Academy of Sciences (2022). On theSindex it has a DataRank of 0. It has been cited 22 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access22 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.28)OA: hybridTopics (47)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Michael J. Topper ORCID,Anna J. Dellomo ORCID,Lora Stojanovic ORCID,Lena J. McLaughlin ORCID,T. Michael Creed

Live enrichment

PubMed:35759659 PMC:PMC9271208 OpenAlex:https://openalex.org/W4283578099

Leukemia Lymphoma Society

Grant: TRP-R6512-19

National Cancer Institute, Cancer Center Support Grant

Grant: P30 CA134274

Dr. Miriam and Sheldon G. Adelson Medical Research Foundation

Grant: 04-7023433

UMB Molecular Medicine Graduate Program

Grant: NA

Van Andel Research Institute

Grant: P50CA254897

FWCI

1.28

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://www.pnas.org/doi/pdf/10.1073/pnas.2123227119

publisherhttps://www.pnas.org/doi/pdf/10.1073/pnas.2123227119

publisherhttps://pnas.org/doi/pdf/10.1073/pnas.2123227119

journalhttps://doi.org/10.1073/pnas.2123227119

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35759659

Fields of Study

interferon and immune responsesPARP inhibition in cancer therapyImmune Cell Function and InteractionAntineoplastic Combined Chemotherapy ProtocolsDNA-Cytosine MethylasesHomologous RecombinationHumansInflammasomesLeukemia, Myeloid, AcuteMembrane ProteinsMutationPoly(ADP-ribose) Polymerase InhibitorsSignal TransductionTumor Suppressor Protein p53STING Protein

MeSH Terms

Poly(ADP-ribose) Polymerase InhibitorsSTING ProteinAntineoplastic Combined Chemotherapy ProtocolsHumansMembrane ProteinsMutationDNA-Cytosine MethylasesSignal TransductionLeukemia, Myeloid, AcuteTumor Suppressor Protein p53InflammasomesHomologous Recombination

Keywords

Myeloid leukemiaBiologyMutantCancer researchImmune systemWild typeInterferonLeukemiaInflammasomeSignal transductionGeneImmunologyInflammationCell biologyGeneticsAMlEpigeneticsCombination therapyTp53Immune Signaling

Sustainable Development Goals

SDG 0: Good health and well-being

Activating STING1-dependent immune signaling in TP53 mutant and wild-type acute myeloid leukemia

FAIR Checklist

Authors (12)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)